Back to search

Article

Clinical evaluation of the Xpert MTB/XDR assay for rapid detection of isoniazid, fluoroquinolone, ethionamide and second-line drug resistance: A cross-sectional multicentre diagnostic accuracy study

2021-05-07

Abstract excerpt

<h4>Background</h4> The WHO End TB Strategy requires universal drug susceptibility testing and treatment of all people with tuberculosis. However, available second-line diagnostic tools are cumbersome and require sophisticated laboratory infrastructure, and ultimately less than half of those with drug-resistant tuberculosis receive appropriate treatment. Xpert MTB/XDR was developed to help overcome these limitatio...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d2c2f5de-0ccf-5182-bc89-d6b60c81dfea
DOI
10.1101/2021.05.06.21256505
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Clinical evaluation of the Xpert MTB/XDR assay for rapid detection of isoniazid, fluoroquinolone, ethionamide and second-line drug resistance: A cross-sectional multicentre diagnostic accuracy studyDOI 10.1101/2021.05.06.21256505
Evaluation of Xpert <sup>®</sup> MTB/XDR test for susceptibility testing of <i>Mycobacterium tuberculosis</i> to first and second-line drugs in UgandaSemantic proximity
Rapid Diagnosis of XDR and Pre-XDR TB: A Systematic Review of Available Tools.Semantic proximity
Access the Diagnostic Accuracy of GeneXpert to Detect <em>Mycobacterium tuberculosis</em> and Rifampicin-Resistance Tuberculosis among Presumptive Tuberculosis and Presumptive Drug Resistant Tuberculosis PatientsSemantic proximity
Epidemiological cut-offs for Sensititre susceptibility testing of Mycobacterium tuberculosis: interpretive criteria cross validated with whole genome sequencingSemantic proximity
Deciphering rifampicin resistance among tuberculosis patients who have trace results on Xpert MTB/RIF ultra assaySemantic proximity
The performance of Xpert MTB/RIF and MTBDRplus within a Programmatic setting at TB Laboratory in Rio de Janeiro, Brazil.Semantic proximity
Performance of an Xpert-based diagnostic algorithm for the rapid detection of drug-resistant tuberculosis among high-risk populations in a low-incidence setting.Semantic proximity
Bedaquiline resistance in patients with Xpert MTB/RIF Ultra-tested rifampicin-resistant tuberculosis in the Western Cape, South Africa: a prospective study.Semantic proximity
Exploring Diagnostic Methods for Drug-Resistant Tuberculosis: A Comprehensive OverviewSemantic proximity
Current Trend in Drug Resistance Pattern Among Extrapulmonary Tuberculosis Cases at Reference Laboratory of Western IndiaSemantic proximity
Analytical performance of a multi-target open real-time PCR assay for simultaneous detection of tuberculosis, non-tuberculous mycobacteria, and drug resistance in a high-burden settingSemantic proximity
Exploring diagnostic methods for drug-resistant tuberculosis: A comprehensive overview.Semantic proximity
Select a neighboring publication to make it the new centre.